DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

Active    As on: 03 March, 2024    Update Info    Print    Share

OVERVIEW - DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

Daewoong Pharmaceutical (India) Private Limited is an unlisted private company incorporated on 30 November, 2012. It is classified as a private subsidiary of a foreign company and is located in Hyderabad, Telangana. It's authorized share capital is INR 2.90 cr and the total paid-up capital is INR 2.86 cr.

Daewoong Pharmaceutical (India)'s operating revenues range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2019. It's EBITDA has increased by 8.53 % over the previous year. At the same time, it's book networth has increased by 163.38 %. Other performance and liquidity ratios are available here.

The current status of Daewoong Pharmaceutical (India) Private Limited is - Active.

The last reported AGM (Annual General Meeting) of Daewoong Pharmaceutical (India) Private Limited, per our records, was held on 27 September, 2023.

Daewoong Pharmaceutical (India) Private Limited has two directors - Chung Hyun Song and Gwan Young Kim.

The Corporate Identification Number (CIN) of Daewoong Pharmaceutical (India) Private Limited is U24232TG2012FTC084511. The registered office of Daewoong Pharmaceutical (India) Private Limited is at PLOT NO.5A, A.P.I.I.C KUKATPALLY, HYDERABAD, Hyderabad, Telangana.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more

REGISTERED DETAILS - DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED


CIN

U24232TG2012FTC084511

Incorporation Date / Age

30 November, 2012 / 12 yrs

Last Reported AGM Date

27 September, 2023


Authorized Capital

INR 290.0 Lacs

Paidup Capital

INR 286.4799 Lacs

industry*

Manufacturing (Chemicals and chemical products)


type

Unlisted Private Company

category

Company limited by Shares

subcategory

Subsidiary of Foreign Company


Email Address

Login for email address. This is to prevent spam.

Website

Website not known. Click here to let us know.

Registered Address

PLOT NO.5A, A.P.I.I.C
KUKATPALLY
HYDERABAD
Hyderabad - 500072
Telangana - India


How to download DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED - Registration Details
CINU24232TG2012FTC084511
Incorporation Date / Age30 November, 2012 / 12 yrs
Last Reported AGM Date27 September, 2023
Authorized CapitalINR 290.0 Lacs
Paidup CapitalINR 286.4799 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeUnlisted Private Company
categoryCompany limited by Shares
subcategorySubsidiary of Foreign Company
Email Address
Website
Registered AddressPLOT NO.5A, A.P.I.I.C KUKATPALLY HYDERABAD Hyderabad - 500072 Telangana - India

FINANCIAL HIGHLIGHTS - DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2019. Actual numbers and updated financial data are included in purchased financial report.
View Sample Report.
Operating Revenue INR 1 cr - 100 cr
EBITDA 8.53 %
Networth 163.38 %
Debt/Equity Ratio 0.01
Return on Equity 11.01 %

* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.

How to get financial reports of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

The company has 2 directors and no reported key management personnel.


The longest serving director currently on board is Chung Hyun Song who was appointed on 08 February, 2016. Chung Hyun Song has been on the board for more than 8 years. The most recently appointed director is Gwan Young Kim, who was appointed on 09 April, 2018.


Chung Hyun Song has the largest number of other directorships with a seat at a total of 1 companies. In total, the company is connected to 0 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
CHUNG HYUN SONG Director 08 February, 2016 No other directorships
GWAN YOUNG KIM Director 09 April, 2018 No other directorships
NAME DESIGNATION APPOINTMENT DATE
CHUNG HYUN SONG Director 08 February, 2016 No other directorships
GWAN YOUNG KIM Director 09 April, 2018 No other directorships
08 February, 2016

CHUNG HYUN SONG

Director

09 April, 2018

GWAN YOUNG KIM

Director

Previous Names

No previous names were found for this company.

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
AMBIC AAYURCHEM LIMITED It was formed in year 2005 in Uttarakhand . The company currently has a paid up capital of INR 2.87 cr.
2005 Uttarakhand 2.87 cr Buy financial reports
BIO-VED PHARMACEUTICALS PRIVATE LIMITED It was formed in year 1995 in Maharashtra . The company currently has a paid up capital of INR 2.87 cr.
1995 Maharashtra 2.87 cr Buy financial reports
BRISC HEALTHCARE PRIVATE LIMITED It was formed in year 2020 in Delhi . The company currently has a paid up capital of INR 2.86 cr.
2020 Delhi 2.86 cr Buy financial reports
RUDRASHRI LIFESCIENCES PRIVATE LIMITED It was formed in year 2022 in Gujarat . The company currently has a paid up capital of INR 2.87 cr.
2022 Gujarat 2.87 cr Buy financial reports
REGE ENGREDEA PRIVATE LIMITED It was formed in year 2013 in Telangana . The company currently has a paid up capital of INR 2.87 cr.
2013 Telangana 2.87 cr Buy financial reports
BEADLETS PHARMA PRIVATE LIMITED It was formed in year 2014 in Telangana . The company currently has a paid up capital of INR 2.87 cr.
2014 Telangana 2.87 cr Buy financial reports
PHYTOCHEM REMEDIES (INDIA) PRIVATE LIMITED It was formed in year 2002 in Rajasthan . The company currently has a paid up capital of INR 2.85 cr.
2002 Rajasthan 2.85 cr Buy financial reports
REGOLA BIO - CHEMICAL PRIVATE LIMITED It was formed in year 2015 in Maharashtra . The company currently has a paid up capital of INR 2.85 cr.
2015 Maharashtra 2.85 cr Buy financial reports
TEX BIOSCIENCES PRIVATE LIMITED It was formed in year 1982 in Tamil Nadu . The company currently has a paid up capital of INR 2.85 cr.
1982 Tamil Nadu 2.85 cr Buy financial reports
ANUSPA HERITAGE PRODUCTS PRIVATE LIMITED It was formed in year 1999 in Maharashtra . The company currently has a paid up capital of INR 2.85 cr.
1999 Maharashtra 2.85 cr Buy financial reports

SUBSIDIARY COMPANIES

No Indian subsidiary companies found.

Company Network - DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

Company Network • Tofler Business Research Platform
How to use company network of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

FAQ - DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED

  • What is the Incorporation date of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED?

    The Incorporation Date of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED is 30 November, 2012.

  • What is the operating revenue of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED?

    The operating revenue of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED is in the range of INR 1 cr - 100 cr for the financial year ending on 31 March, 2019.

  • What is the change in EBITDA of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED since last year?

    The EBITDA of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED has increased by 8.53 % over the previous year. At the same time, it's book networth has increased by 163.38 % for the financial year ending 31 March, 2019.

  • Who are the directors of DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED?

    Daewoong Pharmaceutical (India) Private Limited has two directors - Chung Hyun Song and Gwan Young Kim.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more



Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More